Analysis of B cell subsets for CD19+CD95+ expressing cells showed that the post-switch subset presented the highest expression of CD95+ cells, followed by DN and pre-switch memory B cells, respectively, in RA patients (Figure 2). This evidence concerns the gene FAS and rheumatoid arthritis.